 Jan 04, 2023

Granules to use Greenko's clean energy for proposed INR 2,000 crore plant in
Kakinada & other units

 Nov 03, 2022

JVS Biofuel makes headway on grain-based distillery unit project in Jatwar.

 Sep 07, 2022

Eyestem raises $6.4 mn to solidify cell therapy platform and move their product of
Dry AMD through early clinical trials to an international standard.

 Jul 25, 2022

Biological E to invest Rs 1800 crore in Hyderabad.

 Nov 09, 2021

Union Minister Dr Jitendra Singh inaugurates a new Biotechnology Centre for
Northeast tribals in remote area of Arunachal Pradesh at Kimin.

 Aug 19, 2021

Cabinet approves the Memorandum of Understanding between the Indian Council of
medical Research (ICMR), India and the Foundation for Innovative New Diagnostics
(FIND), Switzerland. 

 Jul 30, 2021

Union Minister Dr Jitendra Singh releases “Biotech-PRIDE (Promotion of Research
and Innovation through Data Exchange) Guidelines.

 Jul 08, 2021

Ivanho Cambridge, Lighthouse Canton To Invest $ 100 Mn In Life Sciences R&D
Facilities In Hyderabad.

 Jun 19, 2021

DBT Issues a Special Call under Biotech KISAN Programme for improving
Agriculture Productivity in the North East Region.

 Nov 18, 2020

Dr. Harsh Vardhan, Union Minister for Health and Family Welfare digitally
addressed the 33rd Stop TB Partnership Board meet where he discussed how India’s
preparation for containing the COVID-19 Pandemic can be repurposed to eradicate
TB by 2025.

 Nov 12, 2020

Serum Institute of India, the world's largest vaccine producer has made 40 million
doses of AstraZeneca's potential Covid-19 vaccine
  Jul 28, 2020
Karnataka to set up ₹5000 cr integrated biotech and life sciences park in
Bengaluru. The 52-acre industrial cluster will form the third component of the
Biohelix Park, aimed at strengthening the biotechnology ecosystem of the State.

 Jul 23, 2020

Serum Institute of India, the world's largest vaccine manufacturer by volume, has
partnered with biopharmaceutical company AstraZeneca to manufacture the
experimental COVID-19 vaccine developed by the University of Oxford.

Biotech recent Trends

Emerging hub for Biosimilars

Over 127 approved biosimilars in the domestic market, more than any other country. It is
estimated that the biologics and biosimilars industry in India will grow at CAGR of 22% to
become USD 12bn by 2025.

Quality infrastructure development

9 Biotech Parks, 4 Biotech Science Clusters and 74+ Bio-Incubators supported by the DBT-
BIRAC.

Leading vaccine manufacturer

Leading global vaccine supplier supplying to over 150 countries with government support -
Mission Indradhanush, Electronic Vaccine Intelligence Network, and National Cold Chain
Management Information System.


National Biopharma Mission - Innovate in India (I3)

DBT and World Bank program with USD 250 Mn of funding with a vision to prepare
India’s technological and product development capabilities in biopharmaceuticals.

Emerging Hub for Bio-IT and Bio-Services

Digitization of health records, the presence of a skilled, English-speaking workforce, and the
low cost of conducting clinical trials have contributed to 19% growth in the segment